1. PHARMACOGENETICS OF ANTITHROMBOTIC DRUGS: STATUS UPDATE ON THE PROBLEM
   Ekaterina S. Kropacheva, 2018, Atherothrombosis Journal CrossRef
2. Impact of genetic and clinical factors on warfarin therapy in patients early after heart valve replacement surgery
   Boxia Li et al, 2019, European Journal of Clinical Pharmacology CrossRef
3. Evidence on the Impact of Pharmacogenetics to Treat and Manage Cardiovascular Diseases
   Xiaoyan Nie et al, 2023, Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy CrossRef
4. Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon
   Marianne Rodrigues Fernandes et al, 2021, Pharmacogenomics and Personalized Medicine CrossRef
5. Landscape of Warfarin and Clopidogrel Pharmacogenetic Variants in Qatari Population from Whole Exome Datasets
   Ambily Sivadas et al, 2016, Pharmacogenomics CrossRef
6. Impact of CYP2C19 Gene Polymorphisms on Warfarin Dose Requirement: A Systematic Review and Meta-Analysis
   Dongxu Wang et al, 2022, Pharmacogenomics CrossRef
7. Clinical and genetic factors influencing acenocoumarol dosing
   Carolina Vázquez et al, 2018, Blood Coagulation & Fibrinolysis CrossRef
8. Influence of CYP2C9, VKORC1, and CYP4F2 polymorphisms on the pharmacodynamic parameters of warfarin: a cross-sectional study
   Kannan Sridharan et al, 2021, Pharmacological Reports CrossRef
9. Effects of Ketoconazole, a CYP4F2 Inhibitor, and CYP4F2*3 Genetic Polymorphism on Pharmacokinetics of Vitamin K1
   Jin‐Woo Park et al, 2019, The Journal of Clinical Pharmacology CrossRef
10. A network meta‐analysis ofCYP2C9,CYP2C9withVKORC1andCYP2C9withVKORC1andCYP4F2genotype‐based warfarin dosing strategies compared to traditional
    Kannan Sridharan et al, 2021, Journal of Clinical Pharmacy and Therapeutics CrossRef
11. Pharmacogenomics Informs Cardiovascular Pharmacotherapy
    Mariana Babayeva et al, 2022, Pharmacogenomics in Drug Discovery and Development CrossRef
12. Genetic Factors Influencing Warfarin Dose in Han Chinese Population: A Systematic Review and Meta-Analysis of Cohort Studies
    Zinan Zhao et al, 2023, Clinical Pharmacokinetics CrossRef
13. Functional Characterization of 29 Cytochrome P450 4F2 Variants Identified in a Population of 8380 Japanese Subjects and Assessment of Arachidonic Acidω-Hydroxylation
    Yu Sato et al, 2023, Drug Metabolism and Disposition CrossRef
14. Association between polymorphisms of the VKORC1 and CYP2C9 genes and warfarin maintenance dose in Peruvian patients
    Teodoro J. Oscanoa et al, 2024, British Journal of Clinical Pharmacology CrossRef
15. Impact of CYP2C19 gene polymorphism on warfarin maintenance doses in patients with non-valvular atrial fibrillation
    Hongshen Zhang et al, 2016, Gene CrossRef
16. Pharmacogenomics of Medications Commonly Used in the Intensive Care Unit
    Shuqin Zhou et al, 2018, Frontiers in Pharmacology CrossRef
17. Can pharmacogenetics help patients under chronic treatment with coumarin anticoagulants?
    Isabel López et al, 2016, Drug Metabolism and Personalized Therapy CrossRef
18. The Impact of Gene Polymorphisms on Anticoagulation Control With Warfarin
    Hai He Jiang et al, 2018, Clinical and Applied Thrombosis/Hemostasis CrossRef
19. Oral anticoagulants: a systematic overview of reviews on efficacy and safety, genotyping, self-monitoring, and stakeholder experiences
    Claire Khouja et al, 2022, Systematic Reviews CrossRef
20. Farmacogenômica e Doença Cardiovascular: Onde Estamos e Para Onde Vamos
    Ricardo Stein et al, 2020, Arquivos Brasileiros de Cardiologia CrossRef
21. Identification of novel CYP4F2 genetic variants exhibiting decreased catalytic activity in the conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE)
    Woo-Young Kim et al, 2018, Prostaglandins, Leukotrienes and Essential Fatty Acids CrossRef
22. Evaluation of supervised machine learning algorithms in predicting the poor anticoagulation control and stable weekly doses of warfarin
    Kannan Sridharan et al, 2023, International Journal of Clinical Pharmacy CrossRef
23. Evidence on the Impact of Pharmacogenetics to Treat and Manage Cardiovascular Diseases
    Xiaoyan Nie et al, 2023, Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy CrossRef